Definitions - WHO
1 Definitions • Pharmacovigilance • Adverse event • Adverse reaction – Unexpected adverse reaction – Serious adverse reaction • Side effect
Download Definitions - WHO
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
240510-Efficacy dementia drugs Drugs avoid …
www.dementiacarestrategies.comMore. . . Copyright © 2008 by Therapeutic Research Center Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ …
Drug, Dementia, 240510 efficacy dementia drugs drugs avoid, 240510, Efficacy, Avoid
rabies position paper august 2010 grading table …
www.who.intWHO Position Paper on Rabies Vaccine ‐ 6 August 2010 Grading of scientific evidence Table I: Efficacy of cell-culture-based rabies vaccines*
STRUCTURE AND CONTENT OF CLINICAL STUDY …
www.ich.orgStructure and Content of Clinical Study Reports 11.4.2.5 Multiple Comparison/Multiplicity.....17 11.4.2.6 Use of an "Efficacy Subset" of Patients.....17
E3 Implementation Working Group ICH E3 Guideline ...
www.ich.orgInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Secretariat, Chemin Louis-Dunant 15, P.O. Box 195, 1211 Geneva 20, Switzerland
Medicines Control Council : General Information
www.kznhealth.gov.zaRegistration of Medicines General Information 2.01 General information Feb08 v4.doc April 2008 Page1 of 48 MEDICINES CONTROL COUNCIL GENERAL INFORMATION
General, Information, Control, Medicine, Council, General information, Medicines control council, Medicines control council general information
Metalux - Cooper Industries
www.cooperindustries.comMetalux The HBLED SE is an outstanding value for a wide variety of applications and mounting heights. Precision designed optics, multiple distributions,
A review of the data on efficacy of handcleaning …
www.hse.gov.ukPrepared by the Health and Safety Laboratory for the Health and Safety Executive 2014 Health and Safety Executive A review of the data on efficacy of
Data, Efficacy, Data on efficacy of handcleaning, Handcleaning
COMPARISON OF IOP LOWERING EFFICACY …
www.mch-ophthal.comcomparison of iop lowering efficacy brimonidine-timolol versus dorzolamide-timolol fixed combination therapy dr. hidayatulla khan, m.s. (ophthalmology)
Comparison, Efficacy, Lowering, Comparison of iop lowering efficacy
CE‐Scale - Wayne K. Hoy
waynekhoy.comCE‐Scale Form L Directions: Please indicate your level of agreement with each of the following statements about